Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking <i>Rb1</i> or <i>Men1</i>
Wenchu Lin(Chinese University of Hong Kong, Shenzhen), Qin Yan(Qingdao University of Science and Technology), David Tuck(Yale University), Mike R. Zou(Yale University), Hideo Watanabe(St. Catherine University), Lauren P. Blair(Alnylam Pharmaceuticals (United States)), Xiaohua Shen(Sir Run Run Shaw Hospital), Jian Cao(Rutgers, The State University of New Jersey), Andrew D. Cherniack(Broad Institute), Dan Kawamori(Osaka City University), Yoji Andrew Minamishima(Cincinnati Children's Hospital Medical Center), Rohit Kulkarni(Joslin Diabetes Center), Sabina Signoretti(Brigham and Women's Hospital), Roderick T. Bronson(Harvard University), Matthew Meyerson(Broad Institute), Scott J. Rodig(Brigham and Women's Hospital), Chiara Grisanzio(Brigham and Women's Hospital), Elizaveta V. Benevolenskaya(University of Illinois Chicago), Jiayun Liu(Harvard University), Joshua M. Francis(Broad Institute), Stuart H. Orkin(Howard Hughes Medical Institute), Yuko Fujiwara(Harvard University), William G. Kaelin(Broad Institute), Christoph Geisen(Harvard University), Zongzhi Liu(Yale University), Qing Zhang(Southwestern Medical Center), Michael L. Beshiri(National Cancer Institute)
Cited by 168
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k